Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CVR Medical Corp V.CVM.H

Alternate Symbol(s):  CRRVF

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool, which complements other stroke screening technology such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA) and computed tomography angiography (CTA). The CSS is non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers.


TSXV:CVM.H - Post by User

Post by Looneytuneson May 13, 2022 7:37am
317 Views
Post# 34680643

Cease Trade Order

Cease Trade OrderThge CTO was put into effect because . . 

1 This is the order of the regulator of the British Columbia Securities Commission (the Decision Maker). ¶

2 The Issuer has not filed the following periodic disclosure required by the Legislation: 1. annual audited financial statements for the year ended December 31, 2021, 2. annual management’s discussion and analysis for the year ended December 31, 2021, 3. certification of annual filings for the year ended December 31, 2021

So lets hope that the funds raised enable the submissions to be made so they can start to focus on the product rather than the regulations.
<< Previous
Bullboard Posts
Next >>